JunLin Xu is an Associate Researcher at Wuhan University of Science and Technology, specializing in bioinformatics, deep learning, cancer genomics, and single-cell multi-omics analysis. They completed their Ph.D. in Computer Science and Technology at Hunan University, focusing on developing computational methods for analyzing biological data. With a strong interdisciplinary background, JunLin’s work bridges computer science, bioinformatics, and medicine, contributing to advancements in understanding complex biological systems and developing novel therapeutic strategies.

Author Metrics

Scopus Profile

Google Scholar Profile

JunLin Xu has an h-index of 12, indicating the impact and productivity of their research output. They have authored a significant number of publications, with a notable number of first-author and corresponding-author papers. This suggests a substantial contribution to the field of bioinformatics and computational biology.

Citations: 655 citations by 469 documents

Documents: 36

h-index: 14

Information:

Xu, Junlin is affiliated with Wuhan University of Science and Technology in Wuhan, China. Their research has garnered 655 citations across 469 documents, with an h-index of 14. They have authored 36 documents in total.

Education

JunLin Xu pursued their education in computer science and mathematics, obtaining a Bachelor’s degree in Mathematics and Applied Mathematics from Nanyang Institute of Technology, followed by a Master’s and Ph.D. in Computer Science and Technology from Hunan University. Their educational background provides a strong foundation for their research in computational biology and bioinformatics.

Research Focus

JunLin Xu’s research focuses on several key areas:

1. Bioinformatics: Developing computational tools and algorithms for analyzing biological data, particularly single-cell omics data.
2. Deep Learning: Exploring the application of deep learning techniques in bioinformatics and genomics research.
3. Cancer Genomics: Investigating the genomics of cancer, including the identification of biomarkers and therapeutic targets.
4. Single-Cell Multi-Omics: Studying the integration of multiple omics data at the single-cell level to gain insights into cellular heterogeneity and disease mechanisms.

Professional Journey

JunLin Xu started their professional journey as an Assistant Researcher at Hunan University, where they gained valuable experience in bioinformatics research. They then progressed to the role of Associate Researcher at the same institution before transitioning to their current position as an Associate Researcher at Wuhan University of Science and Technology. Throughout their career, JunLin has demonstrated a commitment to advancing bioinformatics and computational biology through innovative research and collaboration.

Honors & Awards

While specific honors and awards are not mentioned in the provided information, JunLin Xu’s significant contributions to the field of bioinformatics and computational biology likely garnered recognition from the scientific community. Their publication record and research impact reflect a high level of achievement and potential for future accolades.

Publications Noted & Contributions

JunLin Xu has made notable contributions to the field through a series of impactful publications, addressing various challenges in bioinformatics and genomics research. Their work includes the development of novel computational methods for analyzing single-cell RNA-seq data, drug repositioning strategies, disease association studies, and medical image segmentation. These publications have advanced our understanding of biological systems and have practical implications for disease diagnosis, treatment, and drug discovery.

“Drug repositioning based on tripartite cross-network embedding and graph convolutional network”

• Authors: P Zeng, B Zhang, A Liu, Y Meng, X Tang, J Yang, J Xu
• Published in: Expert Systems with Applications, 2024
• Summary: This paper presents a novel approach to drug repositioning using tripartite cross-network embedding and graph convolutional networks. It proposes a method for leveraging heterogeneous data sources to predict potential drug indications and explore new therapeutic opportunities.

“scDMAE: A Generative Denoising Model Adopted Mask Strategy for scRNA-Seq Data Recovery”

• Authors: W Liu, Y Pan, Z Teng, J Xu
• Published in: IEEE Journal of Biomedical and Health Informatics, 2024
• Summary: This paper introduces scDMAE, a generative denoising model tailored for the recovery of single-cell RNA sequencing (scRNA-Seq) data. The model employs a mask strategy to effectively denoise noisy scRNA-Seq data, enhancing the quality of downstream analysis.

“Drug repositioning based on weighted local information augmented graph neural network”

• Authors: Y Meng, Y Wang, J Xu, C Lu, X Tang, T Peng, B Zhang, G Tian, J Yang
• Published in: Briefings in Bioinformatics, 2024
• Summary: In this work, the authors propose a drug repositioning method that integrates weighted local information into a graph neural network framework. By augmenting the network with local information, the model improves the accuracy of drug repositioning predictions.

“Medical Image Segmentation Using Dual Branch Networks with Embedded Attention Mechanism”

• Authors: S Yang, M Jin, L Wang, C Lu, Y Meng, D Yan, Z Huang, J Xu
• Published in: 2023 IEEE International Conference on Bioinformatics and Biomedicine (BIBM), 2023
• Summary: This conference paper presents a method for medical image segmentation using dual branch networks with an embedded attention mechanism. The approach leverages attention mechanisms to improve the accuracy of segmentation tasks in medical imaging.

“Enhancing drug repositioning through local interactive learning with bilinear attention networks”

• Authors: X Tang, C Zhou, C Lu, Y Meng, J Xu, X Hu, G Tian, J Yang
• Published in: IEEE Journal of Biomedical and Health Informatics, 2023
• Summary: This paper proposes a method for enhancing drug repositioning using local interactive learning with bilinear attention networks. By incorporating attention mechanisms, the model can capture complex relationships between drugs and diseases, improving the effectiveness of drug repositioning strategies.

Research Timeline

• December 2021 – March 2023: Assistant Researcher at Hunan University
• April 2023 – March 2024: Associate Researcher at Hunan University
• April 2024 – Present: Associate Researcher at Wuhan University of Science and Technology

JunLin Xu’s research timeline highlights their progression from an assistant to an associate researcher, indicating their growing expertise and contribution to the field of bioinformatics and computational biology.

Collaborations and Projects

While specific collaborations and projects are not detailed in the provided information, JunLin Xu’s research likely involves collaborations with other researchers, both within their institution and internationally. Their multidisciplinary expertise suggests involvement in diverse projects aimed at addressing key challenges in bioinformatics, genomics, and medicine. These collaborations and projects contribute to the advancement of scientific knowledge and the development of innovative solutions for biomedical research and healthcare.